Clinical Trial

Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty Liver

Name: Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty Liver — clinical trial record (NCT06923215)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

A 12-month prospective observational cohort study assessing eGDR's utility in diagnosing MAFLD (via FibroScan® CAP ≥248 dB/m) and correlating it with steatosis/fibrosis severity. Secondary aims compare eGDR to FLI/FIB-4 scores and identify optimal diagnostic cut-offs

Trial Details

NCT Number	NCT06923215
Lead Sponsor	Assiut University
Conditions	MAFLD
Enrollment	30 participants
Start Date	2025-07-30
Primary Completion	2026-11-30 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2025-04-11